FDBK Stock Overview
A medical imaging technology company, engages in the provision of software and systems to those working in the field of medical imaging. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Feedback plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.17 |
| 52 Week High | UK£1.53 |
| 52 Week Low | UK£0.16 |
| Beta | 0.81 |
| 1 Month Change | -18.29% |
| 3 Month Change | -63.19% |
| 1 Year Change | -76.90% |
| 3 Year Change | -90.43% |
| 5 Year Change | -90.95% |
| Change since IPO | -99.64% |
Recent News & Updates
Shareholder Returns
| FDBK | GB Healthcare Services | GB Market | |
|---|---|---|---|
| 7D | -8.2% | -6.9% | -1.5% |
| 1Y | -76.9% | 13.3% | 3.5% |
Return vs Industry: FDBK underperformed the UK Healthcare Services industry which returned 13.3% over the past year.
Return vs Market: FDBK underperformed the UK Market which returned 3.5% over the past year.
Price Volatility
| FDBK volatility | |
|---|---|
| FDBK Average Weekly Movement | 21.8% |
| Healthcare Services Industry Average Movement | 5.0% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 10.6% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: FDBK's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: FDBK's weekly volatility has increased from 14% to 22% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1958 | 27 | Tom Oakley | fbkmed.com/feedback-plc |
Feedback plc, a medical imaging technology company, engages in the provision of software and systems to those working in the field of medical imaging. Its products include Bleepa, a secure clinical communications and data viewing platform that facilitates the sharing of clinical-grade medical images; CareLocker, a patient centric cloud architecture that provides secure data portability; and Bleepa Box, a technology for sharing DICOM images and other clinical data over mobile networks with the company’s dedicated cloud environment, CareLocker, for subsequent display and review within Bleepa. The company also offers Cadran, a picture archiving storage, management, and display system for medical images; TexRAD, a patent-protected algorithm that extracts and quantifies texture features in pre-existing medical images; and TexRAD Lung, a software tool for the analysis of lung cancer for clinical use.
Feedback plc Fundamentals Summary
| FDBK fundamental statistics | |
|---|---|
| Market cap | UK£2.23m |
| Earnings (TTM) | -UK£3.30m |
| Revenue (TTM) | UK£1.18m |
1.9x
P/S Ratio-0.7x
P/E RatioIs FDBK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FDBK income statement (TTM) | |
|---|---|
| Revenue | UK£1.18m |
| Cost of Revenue | UK£79.13k |
| Gross Profit | UK£1.10m |
| Other Expenses | UK£4.40m |
| Earnings | -UK£3.30m |
Last Reported Earnings
May 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.25 |
| Gross Margin | 93.30% |
| Net Profit Margin | -279.16% |
| Debt/Equity Ratio | 0% |
How did FDBK perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 23:24 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/05/31 |
| Annual Earnings | 2024/05/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Feedback plc is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Dr Julie | Panmure Liberum |
| Julie Simmonds | Panmure Liberum |
| Julie Simmonds | Panmure Liberum Historic (Panmure Gordon) |